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Abstract 
Introduction: Depression in patients with mild cognitive impairment (MCI) and dementia of 
the Alzheimer’s type (AD) is associated with worse prognosis.  Indeed, depressed MCI 
patients have worse cognitive performance and greater loss of gray-matter volume in several 
brain areas.  To date, knowledge of the factors that can mitigate this detrimental effect is still 
limited.  The aim of the present study was to understand in what way cognitive reserve/brain 
reserve and depression interact and are linked to regional atrophy in early stage AD. 
Methods: Depression was evaluated with the Patient Health Questionnaire-9 in 90 patients 
with early AD, and a cut-off of > 5 was used to separate depressed (n = 44) from non-
depressed (n = 46) patients.  Each group was further stratified into high/low cognitive 
reserve/brain reserve.  Cognitive reserve was calculated using years of education as proxy, 
while normalized parenchymal volumes were used to estimate brain reserve.  Voxel-based 
morphometry was carried out to extract and analyze gray-matter maps.  2×2 ANCOVAs were 
run to test the effect of the reserve-by-depression interaction on gray matter.  Age and 
hippocampal ratio were used as covariates.  Composite indices of major cognitive domain 
were also analyzed with comparable models. 
Results: No reserve-by-depression interaction was found in the analytical models of gray 
matter. Depression was associated with less gray matter volume in the cerebellum and 
parahippocampal gyrus.  The brain reserve-by-depression interaction was a significant 
predictor of executive functioning.  Among those with high brain reserve, depressed patients 
had poorer executive skills. No significant results were found in association with cognitive 
reserve. 
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Conclusion: These findings suggest that brain reserve may modulate the association between 
neurodegeneration and depression in patients with MCI and dementia of the AD type, 
influencing in particular executive functioning. 
 
 
Keywords: Alzheimer’s disease, depression, brain reserve, cognitive reserve, voxel-based 
morphometry
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1. Introduction 
The prevalence of depression among people affected by mild cognitive impairment (MCI) and 
early Alzheimer’s disease (AD) has been reported to be high, with figures that vary between 
30% and 50% [1].  Affective symptoms have been found to increase psychological burden in 
caregivers [2] and to have a huge impact on quality of life of patients [3], who are more likely 
to access care facilities at a time earlier than non-depressed patients [4].  Depression in 
patients with AD may play a specific role in accelerating cognitive decline, as found by a 
longitudinal study that reported a faster drop in Mini Mental State Examination scores of 
depressed patients [5].  Moreover, depressive symptoms also affect specific cognitive 
functions, such as episodic memory and working memory [6] and executive functions in 
people with MCI [7]. 
Neuroimaging investigations have shown that depression may worsen the evolution of AD-
related neurodegeneration by fostering loss of gray matter.  Indeed, a study that used voxel-
based morphometry (VBM) found that the co-presence of MCI and depression influences the 
reduction of volume in frontal and temporal areas [8].  Consistently, depressed patients with 
AD, compared to those without depression, showed greater reduction of gray-matter volume 
in the left inferior temporal gyrus [9].  Another study found that depressive symptoms were 
instead associated with cortical thinning in parietal and temporal areas in this same diagnostic 
population [10]. 
Two major factors have long been hypothesized to account for resilience against 
neurodegenerative diseases like AD: brain and cognitive reserve [11].  These concepts may 
explain, in different neurodegenerative conditions, the difference observed between the 
degree of brain damage and the manifestation of clinical symptoms [12]. 
Brain reserve refers to the structural architecture of the brain and it is considered a passive 
model of resilience: the more brain tissue, the more neuropathological damage necessary to 
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cross a threshold that would cause deficits to emerge [13].  Differently, cognitive reserve is an 
active model that describes reserve in terms of flexibility of brain functioning implemented 
during one’s whole life course [13].  Cognitive reserve has mainly been assessed indirectly, 
by means of proxies such as education, level of occupation, mental and physical leisure 
activities [14].  Different studies have shown that both reserve factors seem to have a 
neuroprotective role against the clinical manifestation of AD [15,16]. 
In other words, high levels of brain and cognitive reserve do not prevent the accumulation of 
brain pathology due to AD, but do modulate the symptomatic manifestations [17].  Indeed, 
despite the ongoing progressive pathology, high cognitive reserve might preserve cognitive 
functioning by optimizing the use of brain networks, characterized by greater efficiency or 
capacity, or by fostering compensatory mechanisms [18].  On this note, a VBM study found 
more severe gray matter atrophy in medial temporal areas (particularly susceptible to AD 
pathology) in MCI patients with high cognitive reserve, compared to those with low cognitive 
reserve [19].  The former group showed also larger gray-matter volume in fronto-parietal 
associative regions and better cognitive performance on tasks of visual-spatial and executive 
abilities. 
Hence, cognitive/brain reserve and depression appear to have opposite effects on brain 
atrophy and cognitive functioning.  In a recent work, Opdebeeck et al. [20] investigated in a 
sample of older adults without neurodegenerative diseases whether high cognitive reserve 
(measured as a composite score including education, occupation and social and cognitive 
engagement) could mediate the negative association between mood disturbance and cognitive 
functioning.  They found that cognition was significantly worse in elderly with depression and 
low cognitive reserve compared to those with high cognitive reserve. 
Based on the limited number of studies on the structural brain changes associated with 
depression in patients with MCI and AD and the scarce knowledge about the factors that can 
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mitigate the detrimental effect of this neuropsychiatric symptom on neurological functioning, 
we investigated the possible interaction between depression and measures of cognitive and 
brain reserve.  We chose to rely on a non-clinical cut-off to establish the presence of 
depressive symptoms, rather than to use a measure of depressive symptoms that would 
highlight symptoms of a severity of clinical relevance.  We did so to focus on the mechanisms 
that link reserve and the depression continuum in more general terms without the need to refer 
exclusively to clinically-relevant stages. 
 
 
2. Material and methods 
2.1. Sample 
One-hundred-and-forty-five patients with a clinical diagnosis of amnestic MCI due to AD [21] 
or AD dementia [22] were considered for inclusion in this study.  These patients had been 
recruited from the memory clinics of the Royal Hallamshire Hospital (Sheffield, UK) and the 
nstitute of Clinical Medicine (Kuopio, Finland) as part of the EU-funded (Framework 
Programme 7) “Virtual Physiological Human – DementiA Research Enabled by IT” initiative 
(http://www.vph-dare.eu/) and had passed an initial screening in which major diagnostic 
exclusion criteria were ruled out, including a clinically significant history of mental illness 
and diagnostic elements suggesting potential diagnosis of pseudo-dementia. 
Presence of depressive symptoms was evaluated with the Patient Health Questionnaire (PHQ-
9) [23], a tool that has been shown to have good diagnostic properties in medical populations.  
A score of ≥ 5 was used as cut-off to distinguish depressed from non-depressed patients.  Of 
the 145 patients meeting the study criteria, all those showing depression (n = 46) were 
included.  A group of n = 46 non-depressed patients matched for major demographic variables 
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was also selected.  Of the 92 patients, 2 datasets did not include MRI images and were thus 
discarded, giving a final sample of 90 patients (44 depressed/46 non-depressed, 50 MCI/40 
dementia).  A proportion of these patients also had CSF biomarkers assessments.  The 
complete characterization of the cohort included in the analyses is reported in Table 1. 
 
--- Please insert Table 1 about here --- 
This study was approved by the Yorkshire and Humber Regional Ethics Committee (Ref No: 
12/YH/0474) for the Sheffield cohort and by the ethics committee of the Northern Savonia 
Hospital District for the Kuopio cohort.  Written informed consent was obtained from each 
participant prior to enrollment. 
 
2.2. VBM pre-processing 
For each patient T1-weighted and Fluid-attenuated inversion recovery (FLAIR) scans were 
acquired at 3 T (Philips Ingenia).  3D T1-weighted images were set as follows: gradient echo, 
TR = 8.22 ms, TE = 3.8 ms, matrix 256 × 256, voxel size 0.94 × 0.94 × 1.1 mm3, FOV =  
240°.  FLAIR images were instead recorded with the following specifications: voxel size: 
0.56鳥mm3, TR: 4.8鳥s; TE: 0.20鳥s; matrix size 448鳥×鳥448. 
All analyses were carried out using Statistical Parametric Mapping (SPM) 12 (Wellcome 
Trust Centre for Neuroimaging, London, UK) on MATLAB R2014a (Mathworks Inc., UK).  
T1-weighted images were pre-processed following a two-step VBM procedure: first they 
were reoriented to the bicommissural line and subsequently segmented in order to divide three 
brain tissues, i.e., gray matter, white matter and cerebrospinal fluid.  Furthermore, maps of 
gray matter were normalized and modulated.  Finally, they were smoothed with an 8 mm full-
width at half maximum Gaussian kernel to maximize the signal and minimize artefacts. 
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FLAIR and T1-weighted scans were used to segment white matter lesions automatically using 
the Lesion Segmentation Tool toolbox for SPM [24].  White-matter lesion volume was 
quantified in milliliters and compared across groups to rule out major differences in 
hyperintensity burden. 
Global macro-structural tissue-specific volumes were extracted for the calculation brain 
reserve using the “get_totals” command in Matlab 
(http://www0.cs.ucl.ac.uk/staff/g.ridgway/vbm/get_totals.m). 
 
 
2.3. Cognitive and other clinical variables 
Three indices were created to assess different cognitive domains: episodic memory, semantic 
memory and executive function.  Raw scores were initially transformed into z scores.  Each 
index was then calculated averaging the z scores of specific neuropsychological tests.  In 
detail, the episodic-memory index was constructed based on the delayed recall of the Logical 
Memory Test and two distinct verbal memory tests (assessing word learning and delayed 
recall) administered as part of the Consortium to Establish a Registry for Alzheimer's Disease 
(CERAD) battery [25].  The executive-function index comprised the Digit Span Test - 
Backwards and the Letter Fluency test.  Finally, the semantic-memory index was based upon 
the Category Fluency test, the Similarities tests (as included in the WAIS battery) and the 15-
item Boston Naming included in the CERAD battery. 
Anxiety levels were assessed to characterize the sample more in detail by means of the 
Generalized Anxiety Disorder (GAD-7) [26]. 
Two proxy measures of reserve were used: level of education, quantified in years, for 
cognitive reserve and the parenchymal volume (normalized based on total intracranial volume) 
for brain reserve.  Median values were calculated for each of these two measures in order to 
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split the patient cohort into subgroups of high or low reserve.  The median cut-offs were 11 
years of education for cognitive reserve and 0.67 for brain reserve. 
 
2.4. Statistical analysis  
A 2×2 ANCOVA was run to investigate the voxel-based effect of the interaction between 
depression (present vs. absent) and each measure of reserve (high vs. low) on gray-matter 
maps.  Age and hippocampal ratio were used as covariates.  Hippocampal ratios, calculated as 
a fraction of hippocampal volume (including both left and right hippocampi) divided by total 
gray-matter volume, served to correct for neurodegenerative severity [27]. 
Similarly, 2×2 ANCOVAs were set up to investigate the effect of the interaction on the 
neuropsychological indices (age and hippocampal ratio were used as covariates in these 
models as well).  This second set of analyses was carried out using IBM SPSS Statistics 
Version 24 (IBM, Chicago, IL, USA). 
 
 
3. Results 
3.1. VBM results 
A significant main effect of depression was found in a bilateral cluster extending between 
cerebellar and parahippocampal cortices, with depressed patients showing smaller tissue 
volumes (Table 2).  Concomitantly, a significant main effect of brain reserve was also found 
and this extended widely across most of the brain.  No significant effect of the brain reserve-
by-depression interaction was observed. 
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No significant results were found in association with the models that included cognitive 
reserve.  A trend of smaller volume in cerebellar and temporal regions was found in depressed 
patients, along the same lines as the findings emerging from the analysis of brain reserve. 
 
--- Please insert Table 2 about here --- 
 
3.2. Behavioral results 
In the entire cohort scores on the PHQ-9 questionnaires were significantly correlated with the 
Executive-Functions index (Spearman’s rho = -0.32; p < 0.01), showed a trend association 
with the Semantic-Memory index (Spearman’s rho = -0.19; p = 0.07) and showed no 
significant associations with the Episodic-Memory index.  BR and CR were instead positively 
associated with all three cognitive indices. 
In the 2×2 ANCOVA models the interaction between brain reserve and depression was a 
significant predictor of executive cognitive performance (p = 0.02) (Figure 1).  A main effect 
of brain reserve was observed for all cognitive indices (p < 0.01), with high brain reserve 
associated with better cognitive performance.  Depressed patients obtained significantly lower 
scores on executive functioning than non-depressed patients (p = < 0.01). 
Post hoc analyses were run to characterize the interaction more in detail.  Among patients 
with low brain reserve no differences in cognitive performance were found between those 
with (n = 22) and without depression (n = 23). However, in patients with high brain reserve, 
depressed patients scored significantly worse than non-depressed ones on the indices of 
executive functioning (p < 0.01) and semantic memory (p = 0.02) (Table 3). 
 
--- Please insert Figure 1 and Table 3 about here --- 
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No significant effects emerged from the model testing the interaction between cognitive 
reserve and depression. 
 
3.3. Use of occupational attainment as part of the CR construct 
Details on patients’ lifetime occupations were available for 56 cases.  To compute a more 
elaborate composite index of CR, the procedure described by Garibotto and colleagues [28] 
was followed to combine educational and occupational attainment in the form of an ordinal 
number ranging from 2 to 12.  A median split was then carried out to separate patients with 
low and high CR and post hoc models were run to test the effect of this variable with the same 
methodology as that described in Section 2.4.  No effect of the interaction emerged.  This 
additional CR proxy was, however, associated with grey matter in the inferior frontal gyrus, 
lentiform nucleus and cerebellum, and was also associated with all three cognitive indices:
episodic memory (F = 6.801, p = 0.012), semantic memory (F = 28.179, p < 0.001), and executive 
functions (F = 14.466, p < 0.001).  Since however these results were only found in a sub-sample of the 
original cohort and did not extend to the entire group, their significance can only be interpreted as a 
trend. 
 
 
4. Discussion 
In this study we investigated the interplay between measures of reserve and depression, and 
how this interaction might modulate gray-matter loss and cognitive functioning in a cohort of 
patients diagnosed with MCI or mild dementia of the AD type. 
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Gray matter was not associated with cognitive reserve, neither when main effects nor when 
the interaction with depression symptomatology was studied.  This is likely to be due to the 
fact that VBM, although significant results have been previously observed [19], is not 
sensitive enough to reveal the effect of cognitive reserve on the cerebral structure since this 
factor appears to be mainly related to the functional architecture of the brain [13]. 
Similarly, no interaction was found between levels of brain reserve and presence of 
depression.  This negative finding may indicate that depressive symptoms may manifest as a 
consequence of AD pathology independently of the proportion of neural tissue possessed. 
Indeed, no differences in brain reserve were detected between depressed and non-depressed 
patients.  Nonetheless, self-reported depression appeared to be associated with lower gray 
matter volume, in line with previous knowledge [29,30].  In particular, differences were found 
in a cluster comprising extensive portions of the cerebellum, brain region which appears to 
contribute to regulation of mood [31], and the parahippocampal gyrus, a region particularly 
affected by AD pathology [32,33] and late-life depression [34]. 
From the analyses of cognitive domains in the entire cohort, instead, an interaction between 
brain reserve and depressive symptoms emerged for executive function performance.  Post 
hoc analyses revealed that when patients were split based on their brain-reserve level, 
depression affected those with high brain reserve since in this sub-cohort depressed patients 
performed significantly worse on the executive-function index.  Indeed, depressive symptoms 
in healthy older adults and patients with AD are known to be associated with an impairment 
in executive functions [7,35].  In fact, in our sample the presence of self-reported depressive 
symptoms was associated with worse executive performance, while a significant main effect 
of brain reserve was found predictive of performance on all the three cognitive domains.  
These findings show that, although no modulating effects of brain reserve could be 
14 
 
highlighted at the macro-structural neural level in relation to depression, cognitive 
performance of patients with mood alterations is positively influenced by such variable. 
Cognitive reserve showed instead neither a significant interaction with depressive symptoms 
nor a main effect on cognitive performance.  This may be due to the fact that brain reserve 
may significantly explain variability in cognitive abilities of people affected by AD presenting 
with various degrees of depressed mood better than cognitive reserve.  Indeed, depression in 
AD may, to some extent, be consequential to neurodegenerative changes rather than 
completely due to patients’ awareness of their condition [36].  Thus, possessing more brain 
tissue may modulate the detrimental impact that depression may have on AD-related 
cognitive decline. 
This study is not free from limitations.  Although the PHQ-9 is a useful screening instrument 
that provides a comprehensive summary of the patients’ symptoms in a way that is of easy 
application in secondary and tertiary care units, cut-off values may need adaptation for use 
with people with cognitive impairment [37].  Therefore, more thorough evaluations are 
needed to reach a proper clinical diagnosis of depression.  In fact, an inspection of individual 
PHQ-9 items of available scoresheets revealed that the main symptoms reported were 
insomnia, loss of energy and concentration difficulties.  Vice versa, depressed mood or 
anhedonia, at the basis of a diagnosis of depression according to DSM-5 criteria, were 
reported by very few patients. However, the aim of this study was to investigate depressive 
symptoms, rather than major depressive disorder of clinical relevance.  At the centre of the 
experimental hypothesis was the interactive mechanistic link between reserve and depression.  
A validated clinical cut-off (i.e. PHQ-9 score ≥ 10) may be more indicated for studies 
focusing on clinical depression.  In fact, patients who reported high levels of depressive 
symptoms had no history of depression and were not treated with antidepressants.  
Furthermore, the patients' symptoms might in part originate from increased awareness of their 
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cognitive and functional difficulties, which is supported by increased volumetric integrity 
compared to non-depressed patients.  Moreover, another limitation could be the use of a 
single proxy for cognitive reserve.  A composite index that takes into account additional 
socio-behavioral measures, might be more sensitive to capturing the protective effects of this 
construct. Finally, we also acknowledge that there was no voxel-by-voxel neuropathological 
information coming from in vivo molecular imaging of amyloid and tau depositions.  Such 
piece of evidence would have been extremely informative to interpret the link between grey-
matter volume and the effect of our two predictors (depression and reserve).  Future 
prospective studies are needed to address this shortcoming. 
 
 
5. Conclusion 
These findings suggest that brain reserve modulates the statistical a sociation between 
depression and neurodegenerative processes in patients with MCI and dementia of the AD 
type.  Further investigations are needed to clarify the modulatory role played by cognitive 
reserve in this clinical population.  Further neuroimaging studies may help disentangle the 
influence of these resilience factors, especially using a combination of functional and 
structural MRI, and may provide useful information to treatment research. 
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Figure Caption 
Figure 1 Results of the analysis on the interaction between brain reserve and depression on 
cognitive performance. 
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Table 1. Demographic and neurostructural characteristics of the cohort 
Descriptive Variable Depressed Non-depressed p 
Diagnosis (MCI/AD) 23/21 27/19 0.54 
Age (years) 66.57 (9.93) 67.72 (10.09) 0.59 
Gender (f/m) 21/23 20/26 0.69 
GAD-7 8.20 (5.71) 1.98 (1.86) < 0.01 
Brain Reserve  0.68 (0.08) 0.68 (0.08) 0.81 
Cognitive Reserve (Education years) 11.11 (3.22) 12.07 (3.52) 0.18 
Hippocampal Ratio 1.27e-02 (8.52e-04) 1.26e-02(7.96e-04) 0.43 
White Matter Hyperintensities (ml) 5.52 (7.81) 8.51 (11.52) 0.16 
Counts are reported for dychotomical variables (i.e., diagnosis and gender. Means and 
standard deviations are indicated for all other variables.  Differences in diagnosis and gender 
proportions were tested with a chi-squared test.  All remaining variables were analysed with 
independent-sample t tests. 
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Figure 1 
 
 
 
 
 
 
 
 
Table 2. Main effect of depression on gray matter volume (Non-Depressed > Depressed)  
Cluster  
extent 
Side Brain region t value 
MNI coordinates 
x y z 
11955 R Pyramis 3.12 32 -80 -42 
 L Culmen 3.03 -15 -42 -16 
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 R Dentate nucleus 2.99 12 -54 -34 
 R Inferior semi-lunar lobule 2.86 28 -72 -56 
 R Inferior semi-lunar lobule 2.70 22 -80 -50 
 R Culmen 2.65 18 -33 -14 
 R Culmen 2.63 18 -62 -15 
 R Parahippocampal gyrus 2.58 12 -42 -3 
 R Declive 2.49 26 -72 -27 
 L Declive 2.47 -24 -75 -26 
 R Declive 2.45 36 -78 -28 
 L Vermis 2.35 0 -70 -33 
 R Tonsil 2.25 9 -46 -48 
 R Tonsil 2.24 42 -42 -46 
 L Culmen 2.23 0 -50 -15 
 L Tonsil 2.21 -2 -56 -42 
p < 0.05 FWE 
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Table 3 Post hoc analyses comparing depressed patients with high vs. low brain reserve and 
non-depressed patients with high vs. low brain reserve. The cognitive indices are the result of 
z-score transformation. Mean and standard deviation are included in each cell. 
Cognitive Variable Depressed  Non-Depressed  F p 
Patients with High Brain Reserve 
Episodic-Memory Index 0.15 (0.67) 0.21 (0.83) 1.00 0.76 
Semantic-Memory Index 0.04 (0.53) 0.47 (0.71) 5.85 0.02* 
Executive-Functions Index -0.29 (0.68) 0.66 (0.82) 16.36 < 0.001** 
Patients with Low Brain Reserve 
Episodic-Memory Index -0.23 (1.05) -0.14 (0.97) 0.23 0.63 
Semantic-Memory Index -0.38 (0.91) -0.21 (0.77) 0.53 0.47 
Executive-Function Index -0.27 (0.78) -0.14 (0.77) 0.44 0.51 
 
 
 
 
 
 
 
